Västra Hamnen Market Focus Feed

2026-03-03 09:15:00 Xintela: Moving forward with XSTEM

2026-02-26 08:00:00 Bioextrax: Patience is a virtue

2026-02-24 14:00:00 Bioextrax presenterar Q4 2025

2026-02-17 12:00:00 Advenica: 2025 – another high watermark

2026-02-17 11:07:00 Professor Hall comments on Xintela's study results

2026-02-16 08:00:00 Precise Biometrics: Positioned to rebound

2026-02-13 16:30:00 Crunchfish: The line is cast

2026-02-13 15:15:00 Advenica kommenterar bokslutskommunikén 2025

2026-02-13 11:13:00 Rättelse: Precise Biometrics kommenterar bokslutskommunikén 2025

2026-02-13 10:14:00 Precise Biometrics kommenterar bokslutskommunikén 2025

2026-02-13 08:00:00 Precise Biometrics comments on the year-end report

2026-02-12 12:45:00 Crunchfish comments on the year-end report

2026-01-30 15:00:00 USWE Sports: Trimmar formen inför ny säsong

2026-01-26 18:00:00 Bioextrax: Advancements with the candy producer

2025-12-18 10:30:00 Västra Hamnen Corporate Finance har tagit upp bevakning på Advenica

2025-12-18 10:30:00 Västra Hamnen Corporate Finance initiates coverage of Advenica

2025-12-18 10:00:00 Advenica: Bright prospects in dark times

2025-12-12 10:49:00 Xintela: Extending the financial runway

2025-12-08 16:44:00 aXichem: Nytt avrop från Chr. Olesen

2025-12-01 14:45:00 Gabather: Eager to start the TOTEMS study

2025-12-01 12:00:00 aXichem: Behöver hetta till i Brasilien

2025-11-28 14:30:00 Bioextrax: Financing secured for 2026

2025-11-28 10:03:00 Lipum: Merging with Flerie

2025-11-18 14:00:00 Precise Biometrics: Lower growth, better profitability

2025-11-14 10:30:00 Crunchfish: Laying the foundation

2025-11-12 10:15:00 Xintela: Focus on study results and financing

2025-10-31 09:30:00 USWE Sports: Vinner mark trots osäkerhet i USA

2025-10-24 15:01:00 ProstaLund: Sista rapporten som noterat bolag

2025-10-21 10:30:00 Bioextrax: Which would you like to hear first?

2025-09-05 11:00:00 Xintela: Awaiting final follow-up data

2025-09-05 08:30:00 aXichem: Försäljningstillväxt i prognosen

2025-09-02 12:46:00 ProstaLund: Beslut om avnotering

2025-09-01 13:00:00 Lipum: Finding financial support

2025-09-01 12:00:00 Gabather: TOTEMS-study delayed, not derailed

2025-08-28 12:05:00 Bioextrax: Still awaiting the potential to materialise

2025-08-25 15:00:00 Crunchfish: Episode III: A New Hope

2025-08-19 16:30:00 Precise Biometrics: Market uncertainty slows Q2

2025-08-01 15:30:00 USWE Sports: Ökad omsättning i osäker omvärld

2025-06-19 10:25:00 Gabather: High potential in specific modulation

2025-06-05 14:05:00 Crunchfish’s CEO on new approach

2025-06-03 08:35:00 USWE Sports: Framåtriktat avslut av 2024/25

2025-06-02 15:20:00 Xintela: Taking position for the next phase

2025-06-02 14:45:00 ProstaLund: Räddningsplanka hävde konkurshot

2025-05-26 12:15:00 Crunchfish: Awaiting progress in India

2025-05-23 16:00:00 aXichem: Lovande start på 2025

2025-05-22 14:15:00 Bioextrax: An exciting summer ahead

2025-05-16 16:00:00 Precise Biometrics: Headwind in Q1

2025-05-06 11:15:00 Xintela: Licensing deal with EQGen Biomedical

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Västra Hamnen Market Focus

Prenumeration

Vem äger bolaget?

Västra Hamnen Market Focus

Prenumeration

Vem äger bolaget?

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden